From figures to values: The implicit ethical judgements in our measures of health

Public Health Ethics

Volumn 5, Issue 1, 2012, Pages 22-28

  Vineis, Paolo ^a   Satolli, Roberto ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Zadig   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ARSENIC; DRINKING WATER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROSTATE SPECIFIC ANTIGEN;

ACUTE APPENDICITIS; ARTHRALGIA; ARTICLE; BREAST CANCER; CLINICAL EFFECTIVENESS; ETHICAL DECISION MAKING; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HEALTH CARE COST; HEALTH PROMOTION; HEALTH SERVICE; HEART DISEASE; HERD IMMUNITY; HUMAN; HYPERTENSION; INCIDENTAL FINDING; MAMMOGRAPHY; MEDICAL ETHICS; MORALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUMBER NEEDED TO PREVENT; NUMBER NEEDED TO SCREEN; NUMBER NEEDED TO TEST; NUMBER NEEDED TO TREAT; PATIENT PARTICIPATION; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSTATE CANCER; REFERENCE VALUE; SAMPLE SIZE; SCREENING TEST; SMOKING; TREATMENT OUTCOME;

EID: 84859261573     PISSN: 17549973     EISSN: 17549981     Source Type: Journal    
DOI: 10.1093/phe/phs003     Document Type: Article

References (8)

1. Andriole, G. L., Crawford, E. D., Grubb, R. L. 3rd, Buys, S. S., Chia, D., Church, T. R., Fouad, M. N., Gelmann, E. P., Kvale, P. A., Reding, D. J., Weissfeld, J. L., Yokochi, L. A., O'Brien, B., Clapp, J. D., Rathmell, J. M., Riley, T. L., Hayes, R. B., Kramer, B. S., Izmirlian, G., Miller, A. B., Pinsky, P. F., Prorok, P. C., Gohagan, J. K. and Berg, C. D. (2009). Mortality Results from a Randomized Prostate-cancer Screening Trial. New England Journal of Medicine, 360, 1310-1319.
2. Morris, Z., Whiteley, W. N., Longstreth, W. T. Jr, Weber, F., Lee, Y. C., Tsushima, Y., Alphs, H., Ladd, S. C., Warlow, C., Wardlaw, J. M. and Al-Shahi Salman, R. (2009). Incidental Findings on Brain Magnetic Resonance Imaging: Systematic Review and Meta-Analysis. BMJ, 339, b3016.
3. Schroder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L., Ciatto, S., Nelen, V., Kwiatkowski, M., Lujan, M., Lilja, H., Zappa, M., Denis, L. J., Recker, F., Berenguer, A., Maattanen, L., Bangma, C. H., Aus, G., Villers, A., Rebillard, X., van der Kwast, T., Blijenberg, B. G., Moss, S. M., de Koning, H. J. and Auvinen, A. (2009). Screening and Prostate-cancer Mortality in a Randomized European Study. New England Journal of Medicine, 360, 1320-1328.
4. Schulzer, M. and Mancini, G. B. (1996). 'Unqualified Success' and 'unmitigated Failure': Numberneeded- to-Treat-related Concepts for Assessing Treatment Efficacy in the Presence of Treatmentinduced Adverse Events. International Journal of Epidemiology, 25, 704-712. (Pubitemid 26290051)
5. Vineis, P., Ahsan, H. and Parker, M. (2005). Genetic Screening and Occupational and Environmental Exposures. Journal of Occupational and Environmental Medicine, 62, 657-662, 597. (Pubitemid 41215783)
6. Walter, S. D. (2001). Number Needed to Treat (NNT): Estimation of a Measure of Clinical Benefit. Statistics in Medicine, 20, 3947-3962.
7. Walter, S. D. and Sinclair, J. C. (2009). Uncertainty in the Minimum Event Risk to Justify Treatment was Evaluated. Journal of Clinical Epidemiology, 62, 816-824.
8. Zulman, D. M., Vijan, S., Omenn, G. S. and Hayward, R. A. (2008). The Relative Merits of Populationbased and Targeted Prevention Strategies. Milbank Quarterly, 86, 557-580.